Data as of Oct 17
| +0.69 / +1.41%|
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. Mylan was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.
|Heather M. Bresch||Chief Executive Officer & Director|
|Rajiv Malik||President & Director|
|John D. Sheehan||Chief Financial Officer & Executive Vice President|
|Daniel C. Rizzo||Senior Vice President & Controller|
|Joseph F. Haggerty||Secretary, Senior VP & Global General Counsel|